- Report ID: BMRC 681 | Number of pages: 200 | Publish Date: Feb 2020
Status: Published | Category: Pharmaceutical | Delivery Timeline: 48 hrs
Antiviral Drug Market applies the most effective of each primary and secondary analysis to weighs upon the competitive landscape and also the outstanding market players expected to dominate Antiviral Drug Market place for the forecast 2019– 2025.
Rising occurrence of viral infections such as hepatitis, HIV, influenza, and respiratory syncytial virus is predicted to power the requirement for antiviral drugs. This is predicted to power the requirement for antiviral drugs and efficient treatment solutions.
Antiviral drugs reside in the class of medications, which are employed for treating viral infections, such as herpes, HIV, influenza, and hepatitis. These drugs are normally administered in vaccines form. Moreover, most of these drugs are employed for particular viral infections, while a few are effective in opposition to a wide series of viruses.
The global antiviral drug market is divided by type, mechanism of action, region, and application. By mechanism of action, it is segmented into protease inhibitors, reverse transcriptase inhibitors, nucleotide polymerase inhibitors, and others. By type, it is divided into branded drugs and generic drugs. By application, it is divided into hepatitis, HIV, influenza, herpes, and other viral diseases. The market is segmented by region across Europe (France, Spain, Germany, Italy, UK, and rest of Europe), North America (Canada, U.S., and Mexico), LAMEA (Brazil, South Africa, Saudi Arabia, and rest of LAMEA), and Asia-Pacific (South Korea, China, Japan, Australia, India, and rest of Asia-Pacific).
The major players included in the global antiviral drug market forecast are,
By Mechanism of Action: Nucleotide Polymerase Inhibitors, Reverse Transcriptase Inhibitors, Protease Inhibitors, Others
By Type: Generic, Branded
By Application: HIV, Hepatitis, Herpes, Influenza, Others
The Global Antiviral drug market Is Powered By Rise In The Occurrence Rate Of Viral Infections
The global antiviral drug market is powered by rise in the occurrence rate of viral infections. Moreover, increase in R&D activities and development of advanced & newer formulations, such as combination therapy and vaccines, are predicted to power the growth of the market. On the other hand, high price involved in drug growth and development in the requirement for substitute medicines such as homeopathy and naturopathy restrain the market development. In addition to this, growth opportunities in the emerging nations of LAMEA and Asia Pacific areas and development of broad-spectrum antibiotics are predicted to offer various opportunities for the growth of the market during the coming period. Rising occurrence of viral infections such as hepatitis, HIV, influenza, and respiratory syncytial virus (RSV) is predicted to power the requirement for antiviral drugs. For example, as per data posted by the WHO, hepatitis B led to almost 887,000 deaths in 2015. In addition to this, it was predicted that almost 257 million people in 2015 were suffering from hepatitis B virus (HBV) infection. This is predicted to power the requirement for antiviral drugs and efficient treatment solutions.
Factors such as drop in the cost of US Medicare and competitive dynamics hamper the requirement for antiviral drugs. Moreover, rising awareness about the availability of viral infections’ vaccines and preventive measures will be restraint to the development of antiviral drug market.
North America Led The Global Market With A Huge Share Due To The Attendance Of Major Players In The Area
North America led the global market with a huge share due to the attendance of major players in the area, increasing awareness of viral diseases, and availability of sophisticated healthcare infrastructure. Improving economic stability, increasing patient pool, and the attendance of established & strong generic drugs market in South Asian nations are some of the major factors predicted to offer the market in Asia Pacific with growth avenues. In addition to this, Middle East & Africa is predicted to be one of the quickest developing regions due to rising cases of diseases in nations such as UAE, Qatar, and Saudi Arabia.
Market by Regional Analysis
North America (USA, Canada, Mexico), Europe (UK, France, Germany, Russia, Rest of Europe), Asia-Pacific (China, South Korea, India, Japan, Rest of Asia-Pacific), LAMEA, Latin America, Middle East, Africa
Interested in this report?
Table of Content
Chapter 1 Global Antiviral Drug Market: Summary and Quantitative Analysis
1.1 Report Description
1.2 Global Antiviral Drug Market Revenue Overview
1.3 Global Antiviral Drug Market Revenue (USD Billion) and Growth (%) Rate, 2015- 2025
Chapter 2 Global Antiviral Drug Market: Overview and Qualitative Analysis
2.1 Executive Summary
2.2 Market Drivers
2.2.1 Increasing need to improve the process in order to comply with new standards is anticipated to witness a high growth of Antiviral Drug Market
2.3 Market Restraints
2.4 Market Opportunities
2.5 Market Trends
2.6 Global Antiviral Drug Market: SWOT Analysis
2.7 Global Antiviral Drug Market: PEST Analysis
2.8 Global Antiviral Drug Market: Attractiveness Analysis
2.8.1 Global Antiviral Drug Market: Attractiveness Analysis by Type
2.8.2 Global Antiviral Drug Market: Attractiveness Analysis by Grade
2.8.3 Global Antiviral Drug Market: Attractiveness Analysis by Regional
Chapter 3 Competitive Analysis
3.1 Global Antiviral Drug Market
3.1.1 Global Antiviral Drug market Revenue (USD Billion), By Players 2018
3.1.2 Global Antiviral Drug Market Revenue Share (%), By Players 2018
Chapter 5 Global Antiviral Drug Market: By Types
5.1 Global Antiviral Drug Market Share (%), By Types, 2018
5.2 Global Antiviral Drug Market Revenue (USD Billion), By Types, 2015 – 2025
5.3 Global Antiviral Drug Market Revenue (USD Billion), Based,2015-2025
5.4 Global Antiviral Drug Market Revenue (USD Billion), Based,2015-2025
5.5 Global Antiviral Drug Market Revenue Share (%), By Types, 2015 – 2025
5.6 Global Antiviral Drug Market Revenue Market Share (%), By Types, 2015-2025
Chapter 6 Global Antiviral Drug Market: By Application
6.1 Global Antiviral Drug Market Share (%), By Application, 2018
6.2 Global Antiviral Drug Market Revenue (USD Billion), By Application, 2015 – 2025
6.3 Global Antiviral Drug Market Revenue (USD Billion), Enterprises, 2015-2025
6.4 Global Antiviral Drug Market Revenue (USD Billion),2015-2025
6.5 Global Antiviral Drug Market Revenue Share (%), By Application, 2015 – 2025
6.6 Global Antiviral Drug Market Revenue Market Share (%), By Application, 2015-2025
Chapter 7 North America Antiviral Drug Market Analysis
7.1 North America Market Snapshot
7.1.1 North America Antiviral Drug Market Revenue and Growth Rate (%), 2015-2025.
7.1.2 North America Antiviral Drug Market Revenue (USD Billion) Overview, by Country, 2015 – 2025
7.1.3 North America Antiviral Drug Market Revenue (USD Billion) and Growth Rate (%), 2015 – 2025.
7.1.4 North America Antiviral Drug Revenue (USD Billion) Overview, by Type, 2015-2025
7.1.5 North America Antiviral Drug Revenue (USD Billion) Overview, by Types, 2015-2025
7.1.6 North America Antiviral Drug Revenue (USD Billion) Overview, by Application , 2015-2025
Chapter 8 Europe Antiviral Drug Market Analysis
8.1 Europe Market Snapshot
8.1.1 Europe Antiviral Drug Market Revenue and Growth Rate (%), 2015-2025.
8.1.2 Europe Antiviral Drug Market Revenue (USD Billion) Overview, by Country, 2015 – 2025
8.1.3 Europe Antiviral Drug Market Revenue (USD Billion) and Growth Rate (%), 2015 – 2025.
8.1.4 Europe Antiviral Drug Revenue (USD Billion) Overview, by Type, 2015-2025
8.1.5 Europe Antiviral Drug Revenue (USD Billion) Overview, by Types, 2015-2025
8.1.6 Europe Antiviral Drug Revenue (USD Billion) Overview, by Application, 2015-2025
Chapter 9 Asia Pacific Antiviral Drug Market Analysis
9.1 Asia Pacific Market Snapshot
9.1.1 Asia Pacific Antiviral Drug Market Revenue and Growth Rate (%), 2015-2025.
9.1.2 Asia Pacific Antiviral Drug Market Revenue (USD Billion) Overview, by Country, 2015 – 2025
9.1.3 Asia Pacific Antiviral Drug Market Revenue (USD Billion) and Growth Rate (%), 2015 – 2025.
9.1.4 Asia Pacific Antiviral Drug Revenue (USD Billion) Overview, by Type, 2015-2025
9.1.5 Asia Pacific Antiviral Drug Revenue (USD Billion) Overview, by Types, 2015-2025
9.1.6 Asia Pacific Antiviral Drug Revenue (USD Billion) Overview, by Application, 2015-2025
Chapter 10 Latin America Antiviral Drug Market Analysis
10.1 Latin America Market Snapshot
10.1.1 Latin America Antiviral Drug Market Revenue and Growth Rate (%), 2015-2025.
10.1.2 Latin America Antiviral Drug Market Revenue (USD Billion) Overview, by Country, 2015 – 2025
10.1.3 Latin America Antiviral Drug Market Revenue (USD Billion) and Growth Rate (%), 2015 – 2025.
10.1.4 Latin America Antiviral Drug Revenue (USD Billion) Overview, by Type, 2015-2025
10.1.5 Latin America Antiviral Drug Revenue (USD Billion) Overview, by Types, 2015-2025
10.1.6 Latin America Antiviral Drug Revenue (USD Billion) Overview, by Application, 2015-2025
Chapter 11 Middle East & Africa Antiviral Drug Market Analysis
11.1 Middle East & Africa Market Snapshot
11.1.1 Middle East & Africa Antiviral Drug Market Revenue and Growth Rate (%), 2015-2025.
11.1.2 Middle East & Africa Antiviral Drug Market Revenue (USD Billion) Overview, by Country, 2015 – 2025
11.1.3 Middle East & Africa Antiviral Drug Market Revenue (USD Billion) and Growth Rate (%), 2015 – 2025.
11.1.4 Middle East & Africa Antiviral Drug Revenue (USD Billion) Overview, by Type, 2015-2025
11.1.5 Middle East & Africa Antiviral Drug Revenue (USD Billion) Overview, by Types, 2015-2025
11.1.6 Middle East & Africa Antiviral Drug Revenue (USD Billion) Overview, by Application, 2015-2025
Chapter 12 Competitive Analysis
12.1 COMPANY 1.
12.1.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
12.1.2 COMPANY 1. Total Company Revenue 2015-2018
12.1.3 COMPANY 1. Total Company Revenue, By Segment of Business 2015-2018
12.1.4 COMPANY 1. Total Company Revenue, By Region 2015-2018
12.1.5 COMPANY 1. Global Antiviral Drug Product Category and Description
12.1.6 COMPANY 1. Recent Activity 2015-2019
12.1.7 Main Business/Business Overview
12.1.8 Business Strategy
12.1.9 SWOT Analysis
12.2 Company 2.
12.2.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
12.2.2 Company 2. Total Company Revenue 2015-2018 117
12.2.3 Company 2. Total Company Revenue, By Segment of Business 2015-2018
12.2.4 Company 2. Total Company Revenue, By Region 2015-2018
12.2.5 Company 2. Global Antiviral Drug Product Category and Description
12.2.6 Company 2. Recent Activity 2015-2019
12.2.7 Main Business/Business Overview
12.2.8 Business Strategy
12.2.9 SWOT Analysis
12.3 COMPANY 3
12.3.1 Business Overview
12.3.2 COMPANY 3 Market Product Category and Description & Specification
12.3.3 Main Business/Business Overview
12.3.4 Business Strategy
12.3.5 SWOT Analysis
12.4 COMPANY 4
12.4.1 Business Overview
12.4.2 COMPANY 4 Company Total Company Revenue 2015-2018
12.4.3 COMPANY 4 Company Total Company Revenue, By Segment of Business 2015-2018
12.4.4 COMPANY 4 Company Total Company Revenue, By Region of Business 2015-2018
12.4.5 COMPANY 4 Company Product Category, Specification and Description
12.4.6 COMPANY 4 Company Recent Mergers & Acquisitions (M&A) Activity 2015-2019
12.4.7 COMPANY 4 Company Main Business/Business Overview
12.4.8 Business Strategy
12.4.9 SWOT Analysis
12.5 Company 5
12.5.1 Business Overview
12.5.2 Company 5 Company Net Sales 2015-2018
12.5.3 Company 5 Company Net Sales, By Segment of Business 2011-2018
12.5.4 Company 5 Company Net Sales, By Region 2015-2018
12.5.5 Company 5 Antiviral Drug Market Product Category and Specification
12.5.6 COMPANY 5 Recent Mergers & Acquisitions (M&A) Activity 2015-2019
12.5.7 COMPANY 5 Main Business/Business Overview
12.5.8 Business Strategy
12.5.9 SWOT Analysis
12.6 Company 6
12.6.1 Business Overview
12.6.2 Company 6 Antiviral Drug Market Product Category and Specification
12.6.3 Company 6 Recent Mergers & Acquisitions (M&A) Activity 2015-2019
12.6.4 Company 6 Main Business/Business Overview
12.6.5 Business Strategy
12.6.6 SWOT Analysis
12.7 Company 7
12.7.1 Business Overview
12.7.2 Company 7 Total Company Revenue 2015-2018
12.7.3 Company 7 Total Company Revenue, By Segment of Business 2015-2018
12.7.4 Company 7 Antiviral Drug Market Product Category and Description
12.7.5 Company 7 Recent Mergers &Acquisitions (M&A) Activity 2015-2019
12.7.6 Company 7 Main Business/Business Overview
12.7.7 Business Strategy
12.7.8 SWOT Analysis
Chapter 13 Market Research Findings & Conclusion
Chapter 14 Research Methodology
14.1 Research Process
14.2 Primary Research
14.3 Secondary Research
14.4 Market Size Estimates
14.5 Forecast Model
14.7 Who is This Report For?
14.8 USP’s of Report
List of Figures
FIG. 1 Global Antiviral Drug Market Revenue (USD Billion) and Growth Rate (%), 2015- 2025
FIG. 3 Global Antiviral Drug Market: Attractiveness Analysis by Type
FIG. 4 Global Antiviral Drug Market: Attractiveness Analysis by Types
FIG. 5 Global Antiviral Drug Market: Attractiveness Analysis by Application
FIG. 6 Global Antiviral Drug Market: Attractiveness Analysis by Regional
FIG. 7 Global Antiviral Drug Market
FIG. 8 Global Antiviral Drug Market Share (%), By Type, 2018
FIG. 9 Global Antiviral Drug Market Revenue (USD Billion),
FIG. 10 Global Antiviral Drug Market Revenue (USD Billion),
FIG. 11 Global Antiviral Drug Market Revenue Market Share (%), By Type, 2015-2025
FIG. 12 Global Antiviral Drug Market Share (%), By Types, 2018
FIG. 13 Global Antiviral Drug Market Revenue (USD Billion), 2015-2025
FIG. 14 Global Antiviral Drug Market Revenue (USD Billion), 2015-2025
FIG. 15 Global Antiviral Drug Market Revenue Market Share (%), By Types, 2015-2025
FIG. 16 Global Antiviral Drug Market Share (%), By Application, 2018
FIG. 17 Global Antiviral Drug Market Revenue (USD Billion), By Large Enterprises, 2015-2025
FIG. 18 Global Antiviral Drug Market Revenue (USD Billion), 2015-2025
FIG. 19 Global Antiviral Drug Market Revenue Market Share (%), By Application, 2015-2025
FIG. 20 North America Antiviral Drug Market Revenue (USD Billion) and Growth Rate (%), 2015-2025.
FIG. 21 North America Antiviral Drug Market Revenue (USD Billion) and Growth Rate (%), 2015 – 2025.
FIG. 22 Europe Antiviral Drug Market Revenue (USD Billion) and Growth Rate (%), 2015-2025.
FIG. 23 Europe Antiviral Drug Market Revenue (USD Billion) and Growth Rate (%), 2015 – 2025.
FIG. 24 Asia Pacific Antiviral Drug Market Revenue (USD Billion) and Growth Rate (%), 2015-2025.
FIG. 25 Asia Pacific Antiviral Drug Market Revenue (USD Billion) and Growth Rate (%), 2015 – 2025.
FIG. 26 Latin America Antiviral Drug Market Revenue (USD Billion) and Growth Rate (%), 2015-2025.
FIG. 27 Latin America Antiviral Drug Market Revenue (USD Billion) and Growth Rate (%), 2015 – 2025.
FIG. 28 Middle East & Africa Antiviral Drug Market Revenue (USD Billion) and Growth Rate (%), 2015-2025.
FIG. 29 Middle East & Africa Antiviral Drug Market Revenue (USD Billion) and Growth Rate (%), 2015 – 2025.
FIG. 30 COMPANY 1. Total Company Revenue 2015-2018 (USD Million, R & D Expenses %)
FIG. 31 COMPANY 1. Total Company Revenue, by Segment of Business 2015-2018 (USD Million, AGR %)
FIG. 32 COMPANY 1. Total Company Revenue, by Region 2015-2018 (USD Million, AGR %)
FIG. 33 Company 2. Total Company Revenue 2015-2018 (USD Million)
FIG. 34 Company 2. Total Company Revenue, by Segment of Business 2015-2018 (USD Million, AGR %)
FIG. 35 Company 2. Total Company Revenue, by Region 2015-2018 (USD Million, AGR %)
FIG. 36 COMPANY 4 Company Total Company Revenue 2015-2018 (USD Million)
FIG. 37 COMPANY 4 Company Total Company Revenue, by Segment of Business 2015-2018 (USD Million, AGR %)
FIG. 38 COMPANY 4 Company Total Company Revenue, by Region of Business 2015-2018 (USD Million, AGR %)
FIG. 39 Company 5 Company Net Sales 2015-2018 (USD Million, R & D Expenses %)
FIG. 40 Company 5 Company Net Sales, by Segment of Business 2015-2018 (USD Million, AGR %)
FIG. 41 Company 5 Company Net Sales, by Region 2015-2018 (USD Million, AGR %)
FIG. 42 Company 7 Total Company Revenue 2015-2018 (USD Million, R & D Expenses %)
FIG. 43 Company 7 Total Company Revenue, by Segment of Business 2015-2018 (USD Million, AGR %)
FIG. 44 Primary Research
FIG. 45 Sources of Secondary Research
FIG. 46 Forecast Model
List of Tables
TABLE 1 Global Antiviral Drug Market Overview
TABLE 2 Market Driver Impact Analysis
TABLE 3 Market Restraints Impact Analysis
TABLE 4 Global Antiviral Drug market Revenue (USD Billion), By Players2018
TABLE 5 Global Antiviral Drug market Revenue Market share (%), By Players- 2018
TABLE 6 Global Antiviral Drug Market Revenue (USD Billion), By Product Type, 2015 - 2025
TABLE 7 Global Antiviral Drug Market Revenue Share (%), By Type, 2015 - 2025
TABLE 8 Global Antiviral Drug Market Revenue (USD Billion), By Types, 2015 - 2025
TABLE 9 Global Antiviral Drug Market Revenue Share (%), By Types, 2015 - 2025
TABLE 10 Global Antiviral Drug Market Revenue (USD Billion), By Application, 2015 - 2025
TABLE 11 Global Antiviral Drug Market Revenue Share (%), By Application, 2015 - 2025
TABLE 12 North America Antiviral Drug market Revenue (USD Billion), by Country, 2015 - 2025
TABLE 13 North America Antiviral Drug Revenue (USD Billion), by Type, 2015-2025
TABLE 14 North America Antiviral Drug Revenue (USD Billion), by Types, 2015-2025
TABLE 15 North America Antiviral Drug Revenue (USD Billion), by Application , 2015-2025
TABLE 16 Europe Antiviral Drug market Revenue (USD Billion), by Country, 2015 - 2025
TABLE 17 Europe Antiviral Drug Revenue (USD Billion), by Type, 2015-2025
TABLE 18 Europe Antiviral Drug Revenue (USD Billion), by Types, 2015-2025
TABLE 19 Europe Antiviral Drug Revenue (USD Billion), by Application, 2015-2025
TABLE 20 Asia Pacific Antiviral Drug market Revenue (USD Billion), by Country, 2015 - 2025
TABLE 21 Asia Pacific Antiviral Drug Revenue (USD Billion), by Type, 2015-2025
TABLE 22 Asia Pacific Antiviral Drug Revenue (USD Billion), by Types, 2015-2025
TABLE 23 Asia Pacific Antiviral Drug Revenue (USD Billion), by Application, 2015-2025
TABLE 24 Latin America Antiviral Drug market Revenue (USD Billion), by Country, 2015 - 2025
TABLE 25 Latin America Antiviral Drug Revenue (USD Billion), by Type, 2015-2025
TABLE 26 Latin America Antiviral Drug Revenue (USD Billion), by Types, 2015-2025
TABLE 27 Latin America Antiviral Drug Revenue (USD Billion), by Application, 2015-2025
TABLE 28 Middle East & Africa Antiviral Drug market Revenue (USD Billion), by Country, 2015 - 2025
TABLE 29 Middle East & Africa Antiviral Drug Revenue (USD Billion), by Type, 2015-2025
TABLE 30 Middle East & Africa Antiviral Drug Revenue (USD Billion), by Types, 2015-2025
TABLE 31 Middle East & Africa Antiviral Drug Revenue (USD Billion), by Application, 2015-2025
TABLE 32 COMPANY 1. Basic Information, Manufacturing Base, Sales Area and Its Competitors
TABLE 33 Company 2. Basic Information, Manufacturing Base, Sales Area and Its Competitors
TABLE 34 COMPANY 4 Basic Information, Manufacturing Base and Competitors
TABLE 35 COMPANY 4 Company Basic Information, Manufacturing Base and Competitors
TABLE 36 Company 5 Basic Information, Manufacturing Base and Competitors
TABLE 37 Company 6 Basic Information, Manufacturing Base and Competitors
TABLE 38 Company 7 Basic Information, Manufacturing Base and Competitors
Antiviral Drug Market Size, Share Outlook Growth by Top Company, Development, Application, Segmentation, Trends and Forecast 2020-2025